URGN compared with CADL: revenue, margins and what each company keeps, and the suppliers and customers both name

URGNUroGen Pharma Ltd.

Mkt capRevenueRevenue

CADLCandel Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

URGNUroGen Pharma Ltd.

CADLCandel Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only URGN 6

AGENAgenussupplier

TEVATeva Pharmaceuticals Industriessupplier

—Cenexi-Laboratories Thissenunlistedsupplier

—IconOVir Biounlistedsupplier

2 more · URGN chain ›

Shared 0

No disclosed counterparties: CADL.

Only CADL 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

URGNUroGen Pharma Ltd.

25.78· pre 25.00· delayed

Mkt cap$1.3BRevenue$89MQ3 FY26Revenue$110MFY25

CADLCandel Therapeutics, Inc.

8.04· pre 8.00· delayed

Pre-marketNov 5 '26delayed

Mkt cap$615.2MRevenue—Revenue—

Compare

Pre-marketNov 5 '26delayed

URGNUroGen Pharma Ltd.

CADLCandel Therapeutics, Inc.

25.78pre 25.00delayed

Price

8.04pre 8.00delayed

$1.3B

Mkt cap

$615.2M

Q3 FY26$89M

Revenue

—

FY25$110M

Revenue

—

URGN25.78vsCADL8.04Pre-marketNov 5 '26delayed